메뉴 건너뛰기




Volumn 24, Issue 3, 2011, Pages 583-593

A novel monoclonal antibody against human CD80 and its immune protection in a mouse lupus-like disease

Author keywords

Anti human CD80 antibody; Co stimulatory molecule; Systemic lupus erythematosus

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 4E5; PRISTANE; UNCLASSIFIED DRUG;

EID: 80055118370     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400304     Document Type: Article
Times cited : (25)

References (38)
  • 2
    • 0037902480 scopus 로고    scopus 로고
    • T cell anergy and costimulation
    • DOI 10.1034/j.1600-065X.2003.00009.x
    • Appleman LJ, Boussiotis VA. T cell anergy and costimulation. Immunol Rev 2003; 192:161-80. (Pubitemid 36613331)
    • (2003) Immunological Reviews , vol.192 , pp. 161-180
    • Appleman, L.J.1    Boussiotis, V.A.2
  • 3
    • 34548774646 scopus 로고    scopus 로고
    • Constitutive expression of B7-1 on B cells uncovers autoimmunity toward the B cell compartment in the nonobese diabetic mouse
    • Bour-Jordan H, Salomon BL, Thompson HL, Santos R, Abbas AK, Bluestone JA. Constitutive expression of B7-1 on B cells uncovers autoimmunity toward the B cell compartment in the nonobese diabetic mouse. J Immunol 2007; 179:1004-12.
    • (2007) J Immunol , vol.179 , pp. 1004-1012
    • Bour-Jordan, H.1    Salomon, B.L.2    Thompson, H.L.3    Santos, R.4    Abbas, A.K.5    Bluestone, J.A.6
  • 7
    • 69949148701 scopus 로고    scopus 로고
    • Blocking T cell co-stimulation using a CD80 blocking small molecule reduces delayed type hypersensitivity responses in rhesus monkeys
    • Haanstra KG, Endell J, Estévâo D, Kondova I, Jonker M. Blocking T cell co-stimulation using a CD80 blocking small molecule reduces delayed type hypersensitivity responses in rhesus monkeys. Clin Exp Immunol 2009; 158:91-8.
    • (2009) Clin Exp Immunol , vol.158 , pp. 91-98
    • Haanstra, K.G.1    Endell, J.2    Estévâo, D.3    Kondova, I.4    Jonker, M.5
  • 8
    • 0018953062 scopus 로고
    • Production of monoclonal antibodies: Strategy and tactics
    • DOI 10.1016/0022-1759(80)90146-5
    • Groth SF, Scheidegger D. Production of monoclonal antibodies: strategy tactics. J Immunol Methods 1980; 35:1-21. (Pubitemid 10034772)
    • (1980) Journal of Immunological Methods , vol.35 , Issue.1-2 , pp. 1-21
    • Groth, S.F.1    Scheidegger, D.2
  • 9
    • 33646087182 scopus 로고    scopus 로고
    • Characterization and application of two novel monoclonal antibodies against human OX40: Costimulation of T cells and expression on tumor as well as normal gland tissues
    • Xie F, Wang Q, Chen Y, et al. Characterization and application of two novel monoclonal antibodies against human OX40: costimulation of T cells and expression on tumor as well as normal gland tissues. Tissue Antigens 2006; 67:307-17.
    • (2006) Tissue Antigens , vol.67 , pp. 307-317
    • Xie, F.1    Wang, Q.2    Chen, Y.3
  • 11
    • 38849162227 scopus 로고    scopus 로고
    • Lack of chromatin and nuclear fragmentation in vivo impairs the production of lupus anti-nuclear antibodies
    • Frisoni L, McPhie L, Kang SA, Monestier M, Madaio M, Satoh M, Caricchio R. Lack of chromatin and nuclear fragmentation in vivo impairs the production of lupus anti-nuclear antibodies. J Immunol 2007; 179:7959-66.
    • (2007) J Immunol , vol.179 , pp. 7959-7966
    • Frisoni, L.1    McPhie, L.2    Kang, S.A.3    Monestier, M.4    Madaio, M.5    Satoh, M.6    Caricchio, R.7
  • 12
    • 0033577903 scopus 로고    scopus 로고
    • A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus
    • Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 1999; 189:1639-48.
    • (1999) J Exp Med , vol.189 , pp. 1639-1648
    • Chan, O.T.1    Hannum, L.G.2    Haberman, A.M.3    Madaio, M.P.4    Shlomchik, M.J.5
  • 13
    • 0033214474 scopus 로고    scopus 로고
    • B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity
    • Chan OT, Madaio MP, Shlomchik M. B cells are required for lupus nephritis in the polygenic: Fas-intact MRL model of systemic autoimmunity. J Immunol 1997; 163:3592-96. (Pubitemid 29450878)
    • (1999) Journal of Immunology , vol.163 , Issue.7 , pp. 3592-3596
    • Chan, O.T.M.1    Madaio, M.P.2    Shlomchik, M.J.3
  • 14
    • 0032931973 scopus 로고    scopus 로고
    • Costimulatory regulation of T cell function
    • DOI 10.1016/S0955-0674(99)80027-1
    • Chambers CA, Allison JP. Costimulatory regulation of T cell function. Curr Opin Cell Biol 1999; 11:203-10. (Pubitemid 29164035)
    • (1999) Current Opinion in Cell Biology , vol.11 , Issue.2 , pp. 203-210
    • Chambers, C.A.1    Allison, J.P.2
  • 15
    • 77349107166 scopus 로고    scopus 로고
    • Receptor and ligands implicated in hunman T cell costimulatory process
    • Judith L, Katharina GP, Peter S. Receptor and ligands implicated in hunman T cell costimulatory process. Immunol Lett 2010; 128:89-89.
    • (2010) Immunol Lett , vol.128 , pp. 89-89
    • Judith, L.1    Katharina, G.P.2    Peter, S.3
  • 18
    • 15944368279 scopus 로고    scopus 로고
    • Block and tackle: CTLA4Ig takes on lupus
    • DOI 10.1191/0961203305lu2136oa
    • Davidson A, Diamond B, Wofsy D, Daikh D. Block and tackle: CTLA4Ig takes on lupus. Lupus 2005; 14:197-203. (Pubitemid 40445583)
    • (2005) Lupus , vol.14 , Issue.3 , pp. 197-203
    • Davidson, A.1    Diamond, B.2    Wofsy, D.3    Daikh, D.4
  • 19
    • 77952523821 scopus 로고    scopus 로고
    • Biologic therapy for systemic lupus erythematosus
    • Dall'Era M, Wofsy D. Biologic therapy for systemic lupus erythematosus. Discov Med 2010; 9:20-3.
    • (2010) Discov Med , vol.9 , pp. 20-23
    • Dall'Era, M.1    Wofsy, D.2
  • 20
    • 33846233931 scopus 로고    scopus 로고
    • Inhibiting costimulatory activation of T cells: A viable treatment option for rheumatoid arthritis?
    • DOI 10.2165/00003495-200767010-00001
    • Pollard LC. Inhibiting costimulatory activation of T cells: a viable treatment option for rheumatoid arthritis? Drugs 2007; 67:1-9. (Pubitemid 46105083)
    • (2007) Drugs , vol.67 , Issue.1 , pp. 1-9
    • Pollard, L.C.1
  • 21
    • 34249292281 scopus 로고    scopus 로고
    • Blockade of the 4-1BB (CD137)/4-1BBL and/or CD28/CD80/CD86 costimulatory pathways promotes corneal allograft survival in mice
    • DOI 10.1111/j.1365-2567.2007.02581.x
    • Asai T, Choi BK, Kwon PM, Kim WY, Kim JD, Vinay DS, Gebhardt BM, Kwon BS. Blockade of the 4-1BB (CD137)/4-1BBL and/or CD28/CD80/CD86 costimulatory pathways promotes corneal allograft survival in mice. Immunology 2007; 121:349-58. (Pubitemid 46817356)
    • (2007) Immunology , vol.121 , Issue.3 , pp. 349-358
    • Asai, T.1    Choi, B.K.2    Kwon, P.M.3    Kim, W.Y.4    Kim, J.D.5    Vinay, D.S.6    Gebhardt, B.M.7    Kwon, B.S.8
  • 22
    • 65349188127 scopus 로고    scopus 로고
    • Translating costimulation blockade to the clinic: Lessons learned from three pathways
    • Ford ML, Larsen CP. Translating costimulation blockade to the clinic: lessons learned from three pathways. Immunol Rev 2009; 229:294-306.
    • (2009) Immunol Rev , vol.229 , pp. 294-306
    • Ford, M.L.1    Larsen, C.P.2
  • 23
    • 33745145869 scopus 로고    scopus 로고
    • Chowdhury, Tsokos GC. Autoimmunity in systemic lupus erythematosus: Integrating genes and biology
    • Krishnan SB, Chowdhury, Tsokos GC. Autoimmunity in systemic lupus erythematosus: integrating genes and biology. Semin Immunol 2006; 18:230-43.
    • (2006) Semin Immunol , vol.18 , pp. 230-243
    • Krishnan, S.B.1
  • 24
    • 0032893728 scopus 로고    scopus 로고
    • Differential expression and modulation of costimulatory molecules CD80 and CD86 on monocytes from patients with systemic lupus erythematosus
    • Liu MF, Li JS, Weng TH, Lei HY. Differential expression and modulation of costimulatory molecules CD80 and CD86 on monocytes from patients with systemic lupus erythematosus. Scand J Immunol 1999; 49:82-7.
    • (1999) Scand J Immunol , vol.49 , pp. 82-87
    • Liu, M.F.1    Li, J.S.2    Weng, T.H.3    Lei, H.Y.4
  • 25
    • 24944465752 scopus 로고    scopus 로고
    • Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus
    • DOI 10.1093/rheumatology/keh663
    • Wong CK, Lit LC, Tam LS, Li EK, Lam CW. Abenant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2005; 44:989-94. (Pubitemid 41487170)
    • (2005) Rheumatology , vol.44 , Issue.8 , pp. 989-994
    • Wong, C.K.1    Lit, L.C.W.2    Tam, L.S.3    Li, E.K.4    Lam, C.W.K.5
  • 26
    • 0033072131 scopus 로고    scopus 로고
    • The expression of LFA-1, ICAM-1, CD80 and CD86 molecules in lupus patients: Implication for immunotherapy
    • Takasaki Y, Abe K, Tokano Y, Hashimoto H. The expression of LFA-1, ICAM-1, CD80 and CD86 molecules in lupus patients: implication for immunotherapy. Intern Med 1999; 38:175-77.
    • (1999) Intern Med , vol.38 , pp. 175-177
    • Takasaki, Y.1    Abe, K.2    Tokano, Y.3    Hashimoto, H.4
  • 28
    • 0030904858 scopus 로고    scopus 로고
    • In situ expression of B7 and CD28 receptor families in skin lesions of patients with lupus erythematosus
    • Denfeld RW, Kind P, Sontheimer RD, Schöpf E, Simon JC. In situ expression of B7 and CD28 receptor families in skin lesions of patients with lupus erythematosus. Arthritis Rheum 1997; 40:814-21. (Pubitemid 27199996)
    • (1997) Arthritis and Rheumatism , vol.40 , Issue.5 , pp. 814-821
    • Denfeld, R.W.1    Kind, P.2    Sontheimer, R.D.3    Schopf, E.4    Simon, J.C.5
  • 30
    • 6344275147 scopus 로고    scopus 로고
    • Costimulation requirements of induced murine systemic autoimmune disease
    • Pollard KM, Arnush M, Hultman P, Kono DH. Costimulation requirements of induced murine systemic autoimmune disease.J Immunol 2004; 173:5880-7. (Pubitemid 39392179)
    • (2004) Journal of Immunology , vol.173 , Issue.9 , pp. 5880-5887
    • Pollard, K.M.1    Arnush, M.2    Hultman, P.3    Kono, D.H.4
  • 32
    • 0027938860 scopus 로고
    • Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane
    • DOI 10.1084/jem.180.6.2341
    • Satoh M, Reeves WH. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med 1994; 180:2341-6. (Pubitemid 24351616)
    • (1994) Journal of Experimental Medicine , vol.180 , Issue.6 , pp. 2341-2346
    • Satoh, M.1    Reeves, W.H.2
  • 33
    • 0028845353 scopus 로고
    • Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane
    • Satoh M, Kumar A, Kanwar YS, Reeves WH. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc Natl Acad Sci 1995; 92:10934-38.
    • (1995) Proc Natl Acad Sci , vol.92 , pp. 10934-10938
    • Satoh, M.1    Kumar, A.2    Kanwar, Y.S.3    Reeves, W.H.4
  • 34
    • 33645455804 scopus 로고    scopus 로고
    • Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane)
    • Nacionales DC, Kelly KM, Lee PY, et al. Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl- pentadecane (pristane). Am J Pathol 2006; 168:1227-40.
    • (2006) Am J Pathol , vol.168 , pp. 1227-1240
    • Nacionales, D.C.1    Kelly, K.M.2    Lee, P.Y.3
  • 35
    • 54049138278 scopus 로고    scopus 로고
    • B-cell-directed therapies in systemic lupus erythematosus
    • Arlene TT, Elena P. B-cell-directed therapies in systemic lupus erythematosus. S Arthritis Rheum 2008; 38:218-27.
    • (2008) S Arthritis Rheum , vol.38 , pp. 218-227
    • Arlene, T.T.1    Elena, P.2
  • 36
    • 77956844800 scopus 로고    scopus 로고
    • Therapeutic strategies for SLE involving cytokines: Mechanism-oriented therapies especially IFN-gamma targeting gene therapy
    • Hayashi T. Therapeutic strategies for SLE involving cytokines: mechanism-oriented therapies especially IFN-gamma targeting gene therapy. J Biomed Biotechnol 2010; 2010:1-19.
    • (2010) J Biomed Biotechnol , vol.2010 , pp. 1-19
    • Hayashi, T.1
  • 37
    • 79952481036 scopus 로고    scopus 로고
    • Targeting B cells for the treatment of SLE: The beginning of the end or the end of the beginning?
    • Calero I, Sanz I. Targeting B cells for the treatment of SLE: the beginning of the end or the end of the beginning? Discov Med 2010; 10:416-24.
    • (2010) Discov Med , vol.10 , pp. 416-424
    • Calero, I.1    Sanz, I.2
  • 38
    • 78449260112 scopus 로고    scopus 로고
    • CD3 mAb treatment ameliorated the severity of the cGVHD-induced lupus nephritis in mice by up-regulation of Foxp3+ regulatory T cells in the target tissue: Kidney
    • Zhang JL, Sun DJ, Hou CM, et al. CD3 mAb treatment ameliorated the severity of the cGVHD-induced lupus nephritis in mice by up-regulation of Foxp3+ regulatory T cells in the target tissue: kidney Transpl Immunol 2010; 24:17-25.
    • (2010) Transpl Immunol , vol.24 , pp. 17-25
    • Zhang, J.L.1    Sun, D.J.2    Hou, C.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.